Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Seegene Inc (096530 KS)
Watchlist
103
Analysis
Health Care
•
South Korea
Seegene, Inc. manufactures In Vitro Diagnostic (IVD) products mainly through molecular diagnostic method. The Company provides diagnostic & screening products for cancer, sepsis, influenza and virus infection.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
15 Apr 2021 14:19
The Stocks to Own in Asia – Vol. 32
Our research team constantly reviews the Asian markets to try to find interesting ideas based on Fundamentals or Valuation or Momentum or Risk or...
A. Stotz Investment Research
Follow
565 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 Sep 2020 12:18
The Stocks to Own in Asia – Vol. 30
We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology. Our research team constantly reviews the Asia markets...
A. Stotz Investment Research
Follow
638 Views
Share
bullish
•
Thematic (Sector/Industry)
•
11 Mar 2020 00:58
Full Details & Current Designation List - Short-Selling Restriction Rule Change in Korea
It is now official that we have a new short-selling restriction rule, which is effective as of March 11. For the existing regulations, we now have...
Sanghyun Park
Follow
551 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Dec 2016 08:24
MediSetter Interview:Â Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
Nomadic Equity
4.2k Views
Share
bullish
•
Thematic (Sector/Industry)
•
07 Jul 2016 00:13
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
Sanghyun Park
Follow
3.6k Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x